kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the CYTOF dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for CYTOF.

CYTOF

Altamira Therapeutics Ltd.
Healthcare · Biotechnology
$153.64 sample
+0.10 (+0.07%) 1D
☆ Watch
Market cap
$979.8B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-07
Alerts
8
Price$153.64 +2.07% 3M daily closessample
168.24146.44
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: General Counsel
  • Oct 16INSInsider sell: General Counsel
  • Oct 07SECForm 144 filed
  • Oct 01INSInsider sell: EVP, Operations
  • Sep 22SECDEF 14A filed
  • Sep 15INSInsider sell: Chief Financial Officer
  • Sep 08INSInsider sell: Chief Executive Officer
  • Sep 03INSInsider sell: General Counsel
Sign up to see the real CYTOF record →

Company facts

SEC EDGAR registration
Name
Altamira Therapeutics Ltd.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-35sample, -100 to +100
Reporting currency
USD

Who is positioning in CYTOF

sample
Insiders
13 insider transactions over 90 days, net selling, $504.8M
Congress
2 members traded over 90 days
Institutions · 13F
7 funds hold $20.8B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$64.0B +15.7% y/y
Q4 2024Q3 2026
Inventory$35.7B +10.3% y/y
Q4 2024Q3 2026
Accounts receivable$27.3B +4.7% y/y
Q4 2024Q3 2026
Total debt$75.4B +8.2% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$212.1B -3.1% 3M
Sample peer B
$253.0B +15.8% 3M
Sample peer C
$966.4B +11.1% 3M
Sample peer D
$330.2B +9.5% 3M
Sample peer E
$435.7B +3.0% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not CYTOF's real figure. Nothing here is investment advice.